CFO was honest about the failures of the previous group, but also very optimistic on the future with the new group. Have you taken the time to look at the guys now on the UK team. They are top notch and doing a great job over there. Experienced business guys with connections.
As for not including UK numbers in projections... well that's just Art being conservative. I know we aren't used to that around here. He is only using the numbers from divisions that PCT has direct control over. Since the UK involves working with other parties, he wisely is recognizing that there are elements beyond their control. This doesn't mean things aren't happening. He earlier said it is his belief that revenues will show at the end of Q1 or Q2.
Gary's style was to count every possibility into his projections. We all know how well that went. Art seems to be the opposite, which is why we should pay attention when he says 5-10M for 2022, based on what he deems as solid and bankable projections.
Anyone who wants to look into it, just look at Pathisol and the growth since summer of 2021. Lines up directly with what the company has told us.
The UK PCT/Pathisol deal is happening folks... just need to give it time.
Here's the video linking it all together in case you forgot... notice it was updated this summer to reflect the new label (Pathisol) chosen by the new team
News 
Market Data 
Discover 
